Leen Kawas's most recent trade in Athira Pharma Inc was a trade of 231,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 18, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Athira Pharma Inc | Leen Kawas | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 231,000 | 231,000 | - | - | Stock Option (Right to Buy) |